Abstract:Objective To identify the changes in composition of gut microbiome in patients with different clinical phases of bipolar disorder(BD). Method A total of 28 healthy controls and 31 BD patients including 19 patients with manic episode(BDM group)and 12 patients with depressive episode (BDD group), were enrolled in this study. Baseline characteristics and diet were collected from all participants. Stool samples were collected to extract genomic DNA for PCR and bioinformatics analysis. 16S rRNA sequencing technology was used to obtain gut microbiome diversity among groups subsequently. QIIME was used to calculate observed species index,shannon index,simpson index,psylogenetic diversity index for each group.Linear discriminant analysis(LDA)using LEfSe software was screening for differences species among four groups. Results There was no significant difference between baseline characteristics and diet among four groups. Comparison of gut microbiome alpha diversity among groups, the gut microbiome diversity of BD group were all significantly higher than that in healthy control group,including observed species index(312.0±71.0 vs.229.3±38.6,t=5.475,P<0.01),shannon index(4.9±0.8 vs.3.7±0.9,t=5.747,P<0.01),simpson index(0.9±0.1 vs.0.8±0.1,t=4.446,P<0.01),psylogenetic diversity index(23.7±4.6 vs. 20.2±5.2,t=2.715,P<0.01),especially in BDM group.In composition of gut microbiome(LDA>4,P<0.05)the relative abundance of proteobacteria, ruminococcus, veillonella and lanchnospira in BD group were significantly higher than that in controls, but the relative abundance of bacteroides was significantly lower than that in controls. The relative abundance of enterobacteriaceae, ruminococcus, megamonas and bifidobacterium adolescentis in BDM groups were significantly higher than that in controls,while the relative abundance of bacteroides was significantly lower.The relative abundance of selenomonadales,lachnospira, eubacrerium and plebeius in BDD group were significantly higher than that in controls, while the relative abundance of plebeius was significantly lower. The relative abundance of eschericha coli and bifidobacterium adolescentis of BDM group were significantly higher than that in BDD group, while the relative abundance of stercoris in BDD group was significantly higher than that in BDM group. Conclusion The gut microbiome diversity of patients with BD may be increased and the abundance of several bacterial species changed.

The Microbiome in Bipolar Depression: A Longitudinal Study of One Pair of Monozygotic Twins.

Gut Microbial Clues to Bipolar Disorder: State‐of‐the‐art Review of Current Findings and Future Directions

Gut Microbiota in Bipolar Depression and Its Relationship to Brain Function: an Advanced Exploration

Gut Microbial Signatures Can Discriminate Unipolar from Bipolar Depression

Characteristics of the Gut Microbiota in Bipolar Depressive Disorder Patients with Distinct Weight.

Brain-gut Microbiota Multimodal Predictive Model in Patients with Bipolar Depression

Microbiota Alters and Its Correlation with Molecular Regulation Underlying Depression in PCOS Patients

Causal effects of gut microbiota on the risk of bipolar disorder: a Mendelian randomization study

Systematic identification of the role of gut microbiota in mental disorders: a TwinsUK cohort study

Gut Microbiota – A Potential Contributor in the Pathogenesis of Bipolar Disorder

Bipolar disorder and the gut microbiome: A systematic review

Altered gut bacterial-fungal interkingdom networks in children and adolescents with depression

The Role of the Gut Microbiota in the Development and Progression of Major Depressive and Bipolar Disorder

Gut Microbiota and Bipolar Disorder: An Overview on a Novel Biomarker for Diagnosis and Treatment

Perturbed Gut Microbiota is Gender-Segregated in Unipolar and Bipolar Depression

The Diversity and the Abundance of Gut Microbiome in Patients with Bipolar Disorder

Integrated Multi-Omics Analysis of Gut Microbiome and Serum Metabolome in Unipolar and Bipolar Depression

Reproducible gut microbial signatures in bipolar and schizophrenia spectrum disorders: A metagenome-wide study

Multi-omics analyses of serum metabolome, gut microbiome and brain function reveal dysregulated microbiota-gut-brain axis in bipolar depression

Current Understanding of Gut Microbiota in Mood Disorders: An Update of Human Studies

Gut Microbiota Changes in Patients with Bipolar Depression